Not all down weeks in alexion's base are negative


Play all audios:

In Wednesday's Investor's Corner, IBD emphasized the importance of examining the quality and week-to-week action of a base. Alexion Pharmaceuticals (ALXN), with its strong rally


since 2010 and excellent fundamentals, deserves close examination, even with the elevated risk of its late-stage base status. The stock peaked at 95.01 on March 26, then formed what appears


to be a 12-week flat…